These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31380784)

  • 1. Macozinone: revised synthesis and crystal structure of a promising new drug for treating drug-sensitive and drug-resistant tuberculosis.
    Zhang G; Aldrich CC
    Acta Crystallogr C Struct Chem; 2019 Aug; 75(Pt 8):1031-1035. PubMed ID: 31380784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
    Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Biological Activity of 2-Amino- and 2-aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones.
    Nosova EV; Lipunova GN; Charushin VN; Chupakhin ON
    Mini Rev Med Chem; 2019; 19(12):999-1014. PubMed ID: 30324881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.
    Majewski MW; Tiwari R; Miller PA; Cho S; Franzblau SG; Miller MJ
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2068-71. PubMed ID: 26951749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives.
    Patel KN; Telvekar VN
    Eur J Med Chem; 2014 Mar; 75():43-56. PubMed ID: 24530490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
    Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169).
    Lupien A; Vocat A; Foo CS; Blattes E; Gillon JY; Makarov V; Cole ST
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
    Lv K; Tao Z; Liu Q; Yang L; Wang B; Wu S; Wang A; Huang M; Liu M; Lu Y
    Eur J Med Chem; 2018 May; 151():1-8. PubMed ID: 29601990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents.
    Gao C; Ye TH; Wang NY; Zeng XX; Zhang LD; Xiong Y; You XY; Xia Y; Xu Y; Peng CT; Zuo WQ; Wei Y; Yu LT
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4919-22. PubMed ID: 23886691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis.
    Piton J; Vocat A; Lupien A; Foo CS; Riabova O; Makarov V; Cole ST
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4H-1,3-Benzothiazin-4-one a Promising Class Against MDR/XDR-TB.
    de Souza MVN; Nogueira TCM
    Curr Top Med Chem; 2019; 19(8):567-578. PubMed ID: 30834835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
    Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
    Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitubercular screening of some novel 4H-1,4- benzothiazines and their sulfones under environment benign solvent free conditions as future anti-tubercular agents.
    Guleria A; Jangid DK; Gautam N; Lakhotia R; Chowdhary A; Gautam DC
    Comb Chem High Throughput Screen; 2015; 18(1):48-52. PubMed ID: 25426761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Insight into Dearomatization and Decarbonylation of Antitubercular 4H-Benzo[e][1,3]thiazinones: Stable 5H- and 7H-Benzo[e][1,3]thiazines.
    Richter A; Seidel RW; Graf J; Goddard R; Lehmann C; Schlegel T; Khater N; Imming P
    ChemMedChem; 2022 Mar; 17(6):e202200021. PubMed ID: 35170242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
    Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
    Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiolates chemically induce redox activation of BTZ043 and related potent nitroaromatic anti-tuberculosis agents.
    Tiwari R; Moraski GC; Krchňák V; Miller PA; Colon-Martinez M; Herrero E; Oliver AG; Miller MJ
    J Am Chem Soc; 2013 Mar; 135(9):3539-49. PubMed ID: 23402278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new and potent analogues of anti-tuberculosis agent 5-nitro-furan-2-carboxylic acid 4-(4-benzyl-piperazin-1-yl)-benzylamide with improved bioavailability.
    Tangallapally RP; Lee RE; Lenaerts AJ; Lee RE
    Bioorg Med Chem Lett; 2006 May; 16(10):2584-9. PubMed ID: 16529927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)].
    Mariandyshev AO; Khokhlov AL; Smerdin SV; Shcherbakova VS; Igumnova OV; Ozerova IV; Bolgarina AA; Nikitina NA
    Ter Arkh; 2020 Apr; 92(3):61-72. PubMed ID: 32598795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structures, reactivity and medicinal chemistry of antitubercular benzothiazinones.
    Seidel RW; Richter A; Goddard R; Imming P
    Chem Commun (Camb); 2023 Apr; 59(32):4697-4715. PubMed ID: 36974371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.